Browse Clinical Articles by Topic

Clinical Briefs

In this section: the insulin misadministration problem; comparing smoking cessation pharmacotherapies; more support for ambulatory BP monitoring.

Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate

Tenofovir alafenamide has replaced the tenofovir disoproxil fumarate component of two commonly used drug combinations for HIV-1 infection.

In a large retrospective review of 2137 patients with intracerebral hemorrhage, 34 presented with transient symptoms that could have been misclassified as “transient ischemic attack” if brain imaging had not been performed.

Selecting Patients for Statin Primary Prevention

The new vascular disease risk calculator discriminates who will experience a vascular event in the near future better than using a trial entry criteria approach or a hybrid approach.

Is Anticoagulant Bridging Needed in Patients with Atrial Fibrillation Going to Surgery?

In patients with atrial fibrillation who had warfarin treatment interrupted for an elective operation or other elective invasive procedure, forgoing bridging anticoagulation was not inferior to perioperative bridging with low molecular weight heparin for the prevention of arterial thromboembolism and decreased the risk of major bleeding.

Check coding for intrauterine devices

As of Jan. 1, 2016, the Centers for Medicare & Medicaid Services has discontinued use of HCPCS code J7302 for 52 mg levonorgestrel-releasing IUDs.

Access resource on LARC reimbursement

Obtain appropriate compensation for long-acting reversible contraceptive services with Intrauterine Devices and Implants: A Guide to Reimbursement, a new guide created by the American College of Obstetricians and Gynecologists’ long-acting reversible contraceptive Program, the National Health Law Program, the National Women’s Law Center, the National Family Planning and Reproductive Health Association, and the Bixby Center at the University of California, San Francisco.

Counsel your patients on their risk for pregnancies that are exposed to alcohol

The latest statistics from Centers for Disease Control and Prevention indicate that more than 3 million women between the ages of 15 and 44 are at risk of exposing their developing babies to alcohol because they are drinking and not using birth control to prevent pregnancy.¹ The report also found that three in four women who want to get pregnant as soon as possible do not stop drinking alcohol when they stop using birth control.¹

Management of your patients’ menopause — Is your care on the right track?

By 2020, more than 50 million U.S. women will be older than 51, the mean age when menopause occurs. Despite the availability of effective hormonal and nonhormonal treatments for menopausal symptoms, few women with menopausal symptoms are evaluated or treated, reports a new scientific perspective.

Teen dating violence: Why you should screen

According to the Centers for Disease Control and Prevention, among high school students who date, 21% of females and 10% of males experience physical and/or sexual dating violence.